Date | Insider | Price | Amount |
---|---|---|---|
2-1-2019 Insider Buy |
David C. Longren Director |
$26.50 CAGR » |
$92,750.00 3,500 shares |
11-1-2018 Insider Buy |
Theodore D. Crandall Director |
$27.84 CAGR » |
$111,375.60 4,000 shares |
5-25-2017 Insider Buy |
Craig Wehr Group Ex., President-Zurn |
$23.14 CAGR » |
$17,355.00 750 shares |
8-11-2016 Insider Buy |
David C. Longren Director |
$21.39 CAGR » |
$42,780.00 2,000 shares |
2-4-2016 Insider Buy |
Paul W. Jones Director |
$17.15 CAGR » |
$342,918.00 20,000 shares |
9-4-2015 Insider Buy |
Mark W. Peterson SVP & Chief Financial Officer |
$19.64 CAGR » |
$49,885.60 2,540 shares |
9-3-2015 Insider Buy |
Todd A. Adams President & CEO |
$19.72 CAGR » |
$23,664.00 1,200 shares |
8-14-2015 Insider Buy |
Paul W. Jones Director |
$21.30 CAGR » |
$212,989.00 10,000 shares |
2-10-2015 Insider Buy |
Paul W. Jones Director |
$27.00 CAGR » |
$540,088.00 20,000 shares |
6-4-2014 Insider Buy |
John M. Stropki Director |
$26.66 CAGR » |
$51,587.10 1,935 shares |
2-20-2014 Insider Buy |
John M. Stropki Director |
$28.55 CAGR » |
$50,219.45 1,759 shares |
2-10-2014 Insider Buy |
John M. Stropki Director |
$27.55 CAGR » |
$49,865.50 1,810 shares |
3-29-2012 Insider Buy |
Todd A. Adams President & CEO |
$18.00 CAGR » |
$756,000.00 42,000 shares |
3-29-2012 Insider Buy |
Mark W. Peterson SVP & Chief Financial Officer |
$18.00 CAGR » |
$54,000.00 3,000 shares |
3-29-2012 Insider Buy |
Praveen R. Jeyarajah EVP - Corp. & Bus. Development |
$18.00 CAGR » |
$270,000.00 15,000 shares |
Also See: Institutional Holders of RXN
Also See: SEC filings
Growth of $10,000.00 With Dividends Reinvested |
|||
Start date: | 02/04/2019 | ||
End date: | 10/04/2021 | ||
Start price/share: | $26.37 | ||
End price/share: | $64.95 | ||
Starting shares: | 379.22 | ||
Ending shares: | 385.09 | ||
Dividends reinvested/share: | $0.59 | ||
Total return: | 150.12% | ||
Average Annual Total Return: | 41.09% | ||
Starting investment: | $10,000.00 | ||
Ending investment: | $25,009.82 | ||
Years: | 2.66 | ||
Growth of $10,000.00 Without Dividends Reinvested |
|||
Start date: | 02/04/2019 | ||
End date: | 10/04/2021 | ||
Start price/share: | $26.37 | ||
End price/share: | $64.95 | ||
Dividends collected/share: | $0.59 | ||
Total return: | 148.54% | ||
Average Annual Total Return: | 40.76% | ||
Starting investment: | $10,000.00 | ||
Ending investment: | $24,854.34 | ||
Years: | 2.66 |
RXN Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent RXN insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding RXN
Free RXN Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |